FA Bio Secures £5.3M Funding for Eco-Friendly Microbial Bio-Products
FA Bio, a bio-tech company based in Harpenden, UK, has recently secured £5.3M in funding to further its mission of protecting natural ecosystems through the identification of microbial bio-products. The funding round was led by Clean Growth Fund and Pymwymic, two prominent investors in the biotechnology industry, and saw additional participation from Ship2B Ventures. With this influx of capital, FA Bio plans to focus on commercializing its technology, expanding its research endeavors, and growing its team.
Under the leadership of CEO Dr.
Angela de Manzanos Guinot, FA Bio, previously known as FungiAlert, has been at the forefront of discovering and developing highly effective microbial bioproducts. These bioproducts include biocontrols, biostimulants, and biofertilizers, which can serve as sustainable alternatives to chemical inputs in agriculture. By enforcing the use of natural solutions, FA Bio aims to minimize the environmental impact of agriculture and improve soil health while simultaneously increasing crop yields. The company's innovative SporSenZ technology allows for the efficient discovery and collection of microbes, significantly reducing the typical development time from up to 6 years to approximately 18 months.
Located at the Rothamsted Research Centre in Harpenden, FA Bio benefits from its proximity to this renowned agricultural science facility. The company's microbial discovery platform encompasses a wide range of applications, including disease control, plant growth promotion, and biofertilizer activities. Through its groundbreaking approach, FA Bio is paving the way for a more sustainable and environmentally-friendly future in agriculture.
They've invested in FA Bio
Get to know these Healthtech investors
Click here for a full list of 7,526+ startup investors in the UK